Financial, market and economic news

Protein-based COVID-19 vaccine candidates would be more suitable for India, scientists say

The decision on procuring the right COVID-19 vaccine depends on multiple factors, including safety, price and ease of deployment, the scientists added, pitching for a preventive like the one being developed by US firm Novavax that can be stored at lower temperatures rather than those developed from mRNA or viral vectors.

Read More

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More

Privacy & Cookies Policy